View Older Stories View More Recent Stories

Oct 3, 2022 08:00AM Lineage Establishes New R&D Facility in U.S. and Expands Current GMP Manufacturing Facility in Israel
Aug 15, 2022 08:00AM Lineage to Present at H.C. Wainwright & Co. 2nd Annual Virtual Ophthalmology Conference
Aug 11, 2022 04:05PM Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
Aug 4, 2022 08:00AM Lineage Cell Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on August 11, 2022
Jun 2, 2022 08:00AM Lineage Broadens Collaboration With Advanced BioMatrix for HyStem® Cell Drug Delivery Technology
May 12, 2022 04:05PM Lineage Cell Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
May 5, 2022 08:00AM Lineage Cell Therapeutics to Report First Quarter 2022 Financial Results and Provide Business Update on May 12, 2022
May 3, 2022 08:01AM Lineage Cell Therapeutics (LCTX) Reports RG6501 Phase 1/2a Clinical Results Support the Potential for OpRegen to Slow, Stop or Reverse Disease Progression in Geographic Atrophy Secondary to Age-Relate
May 3, 2022 08:00AM RG6501 (OpRegen®) Phase 1/2a Clinical Results Support the Potential for OpRegen to Slow, Stop or Reverse Disease Progression in Geographic Atrophy Secondary to Age-Related Macular Degeneration
Apr 26, 2022 08:00AM Lineage to Present at B. Riley Securities 2022 Neuro & Ophthalmology Virtual Investor Conference on April 27, 2022
Apr 25, 2022 08:00AM Lineage Announces a Fifth Cell Therapy Program: Allogeneic Photoreceptor Transplants for the Treatment of Diseases Which May Lead to Blindness
Apr 13, 2022 08:00AM Lineage and Cancer Research UK Announce Completion of Patient Enrollment in Phase 1 Clinical Study of VAC2 for the Treatment of Non-small Cell Lung Cancer
Apr 11, 2022 08:00AM Lineage to Present at the NobleCon18 Investor Conference on April 20, 2022
Mar 24, 2022 08:00AM Lineage to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC on March 28, 2022
Mar 21, 2022 08:00AM Lineage Announces Pipeline Expansion to Include Auditory Neuronal Cell Therapy for Treatment of Hearing Loss
Mar 14, 2022 08:00AM RG6501 (OpRegen®) Full Phase 1/2a Results to Be Featured at 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Presentation by Allen C. Ho, M.D., FACS
Mar 10, 2022 04:05PM Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Mar 1, 2022 08:00AM Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Business Update on March 10, 2022
Jan 24, 2022 08:00AM Lineage to Present at B. Riley Securities 2022 Virtual Oncology Conference on January 27, 2022
Jan 4, 2022 08:00AM Lineage Cell Therapeutics to Present at H.C. Wainwright Bioconnect Virtual Conference
Dec 20, 2021 06:00AM Lineage Establishes Exclusive Worldwide Collaboration With Genentech for the Development and Commercialization of OpRegen® RPE Cell Therapy for the Treatment of Ocular Disorders
Nov 30, 2021 08:00AM Lineage Reports Fourth Case of Retinal Tissue Restoration With OpRegen®
Nov 15, 2021 08:00AM OpRegen® Clinical Data Presented at 125th Annual American Academy of Ophthalmology Meeting by Michael S. Ip, M.D.
Nov 10, 2021 04:05PM Lineage Reports Third Quarter 2021 Financial Results and Highlights Progress From Clinical Cell Therapy Programs
Nov 3, 2021 08:00AM Lineage Cell Therapeutics to Report Third Quarter 2021 Financial Results and Provide Business Update on November 10, 2021
Oct 26, 2021 08:00AM OpRegen® Data Update to Be Featured at 2021 American Academy of Ophthalmology Annual Meeting in Presentation by Michael S. Ip, M.D.
Oct 18, 2021 08:00AM Lineage to Be Featured in B. Riley Securities Fall 2021 “Growth Biotech Best Ideas” Virtual Series on October 18, 2021
Sep 30, 2021 10:53AM Lineage Cell Therapeutics (LCTX) Announces Promising New OpRegen Clinical Data Featured at 54th Annual Retina Society Meeting
Sep 30, 2021 10:52AM Promising New OpRegen® Clinical Data Featured at 54th Annual Retina Society Meeting in Podium Presentation by Christopher D. Riemann, M.D.
Sep 20, 2021 08:00AM Lineage to Present at the 2021 Cantor Virtual Global Healthcare Conference on September 27, 2021
Sep 15, 2021 09:05AM Lineage Cell (LCTX) Announces Data From Clinical Trial Continues to Demonstrate Single Administration of OpRegen Can Provide Anatomical and Functional Improvements in Patients With Dry AMD With Geogra
Sep 15, 2021 09:00AM Data From Ongoing Clinical Trial Continues to Demonstrate a Single Administration of OpRegen® Can Provide Anatomical and Functional Improvements in Patients With Dry AMD With Geographic Atrophy
Sep 13, 2021 08:00AM Opregen® Data Update Will Be Featured at 54th Annual Retina Society Meeting in Podium Presentation by Christopher D. Riemann, M.D.
Sep 1, 2021 08:00AM Lineage Announces Appointment of General Counsel
Aug 12, 2021 04:05PM Lineage Reports Second Quarter 2021 Financial Results and Highlights Additional Progress From Clinical Cell Therapy Programs
Aug 10, 2021 08:00AM Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021
Aug 5, 2021 08:00AM Lineage Cell Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on August 12, 2021
Jul 20, 2021 08:08AM Lineage Cell Therapeutics (LCTX) Says OpRegen Clinical Data Continues to Demonstrate Functional and Anatomical Improvements in Patients With Dry AMD With Geographic Atrophy
Jul 20, 2021 08:00AM OpRegen® Clinical Data Continues to Demonstrate Functional and Anatomical Improvements in Patients With Dry AMD With Geographic Atrophy
Jul 13, 2021 08:00AM OpRegen® Data Update to Be Featured at 54th Annual Retina Society Meeting in Podium Presentation by Christopher D. Riemann, M.D.
Jun 28, 2021 08:00AM Lineage Cell Therapeutics Joins Russell 3000® and Russell Microcap® Indexes
Jun 22, 2021 06:50AM Lineage’s OPC1 Cell Therapy for the Treatment of Spinal Cord Injury to Return to Clinical Testing
Jun 17, 2021 08:04AM Lineage Cell Therapeutics (LCTX) Announces Exclusive Option Agreement With Amasa Therapeutics for Supply and Use of Clinical-Grade Hystem
Jun 17, 2021 08:00AM Lineage Announces Exclusive Option Agreement With Amasa Therapeutics for Supply and Use of Clinical-Grade Hystem®
Jun 16, 2021 06:50AM Lineage Cell Therapeutics (LCTX) Announces Kevin L. Cook to Join as Chief Financial Officer
Jun 16, 2021 06:50AM Lineage Cell Therapeutics Announces Kevin L. Cook to Join as Chief Financial Officer
Jun 15, 2021 08:00AM Lineage Cell Therapeutics to Present at Raymond James 2021 Human Health Innovation Conference on June 22, 2021
Jun 9, 2021 08:00AM Lineage Cell Therapeutics Set to Join Russell 3000® Index and Russell Microcap® Index
Jun 3, 2021 08:00AM Lineage Cell Therapeutics to Host Webinar With Therapeutic Area Experts to Discuss Retinal Tissue Restoration Observed in Dry AMD Patients Treated With OpRegen®
Jun 1, 2021 06:32AM Lineage Cell Therapeutics (LCTX) Reports Additional Cases of Retinal Tissue Restoration in Dry AMD Patients Treated With OpRegen RPE Cells
View More Recent Stories View Older Stories